1. The growing burden of liver cirrhosis: implications for preventive measures

   • Martin C. S. Wong
   • Junjie Huang

   Editorial 20 April 2018 Pages: 201 - 203

2. Beyond KCH selection and options in acute liver failure

   • William Bernal
   • Roger Williams

   Review Article Open access 01 June 2018 Pages: 204 - 213

   

3. Glecaprevir/pibrentasvir expands reach while reducing cost and duration of hepatitis C virus therapy

   • Ameer Abutaleb
   • Shyam Kottilil
   • Eleanor Wilson

   Review Article 29 May 2018 Pages: 214 - 222

4. Immune checkpoint receptors: homeostatic regulators of immunity

   • Antonio Riva
   • Shilpa Chokshi

   Review Article Open access 08 May 2018 Pages: 223 - 236

   

5. Platelets’ increase is associated with improvement of liver fibrosis in entecavir-treated chronic hepatitis B patients with significant liver fibrosis

   • Lin Wang
   • Bingqiong Wang
   • Jidong Jia

   Original Article 26 April 2018 Pages: 237 - 243

   

6. Safety and effectiveness of daclatasvir and asunaprevir dual therapy in patients with genotype 1 chronic hepatitis C: results from postmarketing surveillance in Japan

   • Fumitaka Suzuki
   • Naoya Hatanaka
   • Akira Komoto

   Original Article 09 June 2018 Pages: 244 - 253

   

7. Tsumura-Suzuki obese diabetic mice-derived hepatic tumors closely resemble human hepatocellular carcinomas in metabolism-related genes expression and bile acid accumulation

   • Tetsuyuki Takahashi
   • Ulrich Deuschle
   • Koichi Tsuneyama

   Original Article 12 April 2018 Pages: 254 - 261

   

8. Analysis of the high incidence of acute kidney injury associated with acute-on-chronic liver failure

   • Nan Chen
   • Xiaohong Chen
   • Jie Teng

   Original Article 28 April 2018 Pages: 262 - 268

   

9. Liver cirrhosis and cancer: comparison of mortality

   • Wankyo Chung
   • Changik Jo
   • Dong Joon Kim

   Original Article 01 March 2018 Pages: 269 - 276

   

10. Plasma miRNA-122-5p and miRNA-151a-3p identified as potential biomarkers for liver injury among CHB patients with PNALT

    • Jin-Lin Cheng
    • Hong Zhao
    • Lan-Juan Li

    Original Article 07 June 2018 Pages: 277 - 287

    

11. Correction to: Abstracts of the 27th Annual Conference of APASL, March 14–18, 2018, New Delhi, India

    Correction 23 May 2018 Pages: 288 - 288

12. Correction to: Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B

    • Tianyu He
    • Yuqing Bai
    • Jidong Jia

    Correction 11 June 2018 Pages: 289 - 289